NCT04110366View on ClinicalTrials.gov

Nasal and Systemic Immune Responses to Nasal Influenza Vaccine

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 14, 2018

Primary Completion Date

April 4, 2019

Study Completion Date

May 29, 2020

Conditions
InfluenzaVaccine Virus Shedding
Interventions
BIOLOGICAL

Live attenuated influenza vaccine

Vaccination with live attenuated influenza vaccine (LAIV)

OTHER

Vehicle control

Vehicle control nasal challenge

Trial Locations (1)

W2 1PG

Imperial Clinical Respiratory Research Unit, London

All Listed Sponsors
lead

Imperial College Healthcare NHS Trust

OTHER

NCT04110366 - Nasal and Systemic Immune Responses to Nasal Influenza Vaccine | Biotech Hunter | Biotech Hunter